- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 35/18 - Erythrocytes
Patent holdings for IPC class A61K 35/18
Total number of patents in this class: 414
10-year publication summary
|
30
|
31
|
46
|
55
|
53
|
47
|
40
|
22
|
27
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Rubius Therapeutics, Inc. | 75 |
38 |
| Erytech Pharma | 72 |
24 |
| RegenLab USA LLC | 70 |
16 |
| Hemanext Inc. | 84 |
15 |
| The Regents of the University of California | 19544 |
12 |
| Biomet Manufacturing, LLC | 1031 |
12 |
| Biomet, Inc. | 121 |
7 |
| Boston Medical Center Corporation | 110 |
7 |
| ZB Manufacturing, LLC | 120 |
7 |
| Cerus Corporation | 93 |
6 |
| Trustees of Boston University | 966 |
6 |
| Sangamo Therapeutics, Inc. | 425 |
6 |
| The General Hospital Corporation | 4651 |
5 |
| Terumo Kabushiki Kaisha | 5399 |
5 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3052 |
5 |
| ViaCell, LLC | 6 |
5 |
| Whitehead Institute for Biomedical Research | 315 |
5 |
| Beam Therapeutics Inc. | 210 |
5 |
| Westlake Therapeutics (Hangzhou) Co. Limited | 17 |
5 |
| Fenwal, Inc. | 648 |
4 |
| Other owners | 219 |